Thermo Fisher Scientific is proud to be leading the way by delivering state of the art I/O research tools and lectures at EACR25!!

Thermo Fisher Scientific’s Clinical Sequencing Division launches Clinical Decision Support SW at ECP 2018!

Thermo Fisher Scuentific’s Clinical Sequencing Division launches Oncomine TMB plus Variant Calling at ECP 2018!

Great to visit with Dr. Jacqui Shaw’s outstanding Team at University of Leicester!!

Thermo Fisher Scientific’s Dr. Cristina Van Loy presents AmpliSeq HD at ECP 2018!!

Thermo Fisher Scientific’s Dr. Ruchi Chaudhary presents the new Oncomine TML Assay plus Variant Calling at ECP 2018!

Thermo Fusher Scientific’s Dr.Santhoshi Bandla presents an integrative NGS and cytogenetics solution for Myeloid Cancer Research at ECP 2018!

Thermo Fisher Scientific’s Denise Topacio-Hall describing the new TCR beta Immune Repertoire S_R Assay for FFPE Specimens at ECP 2018!

Dr. Matt Hiemenz presenting at Thermo Fisher Scientific’s Global COE Summit 2018 on his groundbreaking work with Dr. Tim Triche, Children’s Hospital LA/USC regarding the Oncomine Childhood Cancer Research Assay!!

BloodPAC’s Analytical Working Group meets with FDA to discuss finalization of its proposed “Generic Analytical Vslidstion Protocols for cell free Assay Performance Verication” document.

BloodPAC’s Analytical Validation Working Group meets with FDA to discuss finalization of its proposed “Generic Analytical Validation Protocols for Cell Free Assay Performance Verification” document.

“Democratization and Globalization of Next Generation Sequencing for Companion Diagnostics” presentation by #BlooodPAC member Thermo Fisher #JimGodsey. Finding ways to improve #patientoutcomes and #patientbenefit. #LiquidBiopsy #data #collaboration #BioTECHsummit EPM Group

By simplifying and accelerating next-generation sequencing workflows with innovative products, we move closer to fulfilling the promise of precision medicine.

Honored to be a first author of BLOODPAC’s publication to define industry standards, accelerating the development of #liquidbiopsy assays to improve cancer care.

Honored to be a first author of BLOODPAC’s publication to define industry standards, accelerating the development of #liquidbiopsy assays to improve cancer care.

BloodPAC Publishes FDA-Reviewed Validation Protocols for Liquid Biopsy<p ... bloodpac.org/news/2020/8/31…

Analytical Validation WG co-chairs Jim Godsey & #JonBaden on the progress of the #MRD & #bTMB protocols. Pre-subs to be submitted within the next two months Friends of Cancer Research Bristol Myers Squibb Personal Genome Diagnostics (PGDx) AstraZenecaUS Guardant Health FDA Medical Devices Illumina Foundation Medicine @SeraCare UAMS Cancer

Outstanding article by Jon Gertner in @NYTmagazine providing historical perspective on science/industry's collaboration to respond to Covid Pandemic. Features Illumina's NovaSeq 6000 in Covid Surveillance role! #COVIDsurveillance urldefense.com/v3/__https://w…$

Announcing the updated Infinium Global Diversity Array with Enhanced PGx. This new array provides clinical researchers with 100% more PGx content driving breakthroughs in medication management. illumina.com/company/news-c…

Thermo Fisher Scientific participating as the Blood Profiling Atlas takes another step closer to bringing liquid biopsies to the clinic!